Open access · CC-BY
via OpenAlex
Mesenchymal stem cell therapy in the treatment of hip osteoarthritis
RODRIGO M. MARDONES, Claudio M. Jofré, L. Tobar, José J. Minguell
Journal of Hip Preservation Surgery · 2017 · ▲ 70 citations
Abstract
This study was performed to investigate the safety and efficacy of the intra-articular infusion of ex vivo expanded autologous bone marrow-derived mesenchymal stem cells (BM-MSC) to a cohort of patients with articular cartilage defects in the hip. The above rationale is sustained by the notion that MSCs express a chondrocyte differential potential and produce extracellular matrix molecules as well as regulatory signals, that may well contribute to cure the function of the damaged hip joint. A cohort of 10 patients with functional and radiological evidences of hip osteoarthritis, either in one or both legs, was included in the study. BM-MSC (the cell product) were prepared and infused into the damaged articulation(s) of each patient (60 × 106 cells in 3 weekly/doses). Before and after completion of the cell infusion scheme, patients were evaluated (hip scores for pain, stiffness, physical function, range of motion), to assess whether the infusion of the respective cell product was beneficial. The intra-articular injection of three consecutive weekly doses of ex vivo expanded autologous BM-MSC to patients with articular cartilage defects in the hip and proved to be a safe and clinically effective treatment in the restoration of hip function and range of motion. In addition, the statistical significance of the above data is in line with the observation that the radiographic scores (Tönnis Classification of Osteoarthritis) of the damaged leg(s) remained without variation in 9 out of 10 patients, after the administration of the cell product.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/jhps/hnx011
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
MARDONES, R.M., Jofré, C.M., Tobar, L., & Minguell, J.J. (2017). Mesenchymal stem cell therapy in the treatment of hip osteoarthritis. <em>Journal of Hip Preservation Surgery</em>. https://doi.org/10.1093/jhps/hnx011
Vancouver
MARDONES RM, Jofré CM, Tobar L, Minguell JJ. Mesenchymal stem cell therapy in the treatment of hip osteoarthritis. Journal of Hip Preservation Surgery. 2017. doi:10.1093/jhps/hnx011.
BibTeX
@article{rodrigo2017Mesenc,
title = {Mesenchymal stem cell therapy in the treatment of hip osteoarthritis},
author = {RODRIGO M. MARDONES and Claudio M. Jofré and L. Tobar and José J. Minguell},
journal = {Journal of Hip Preservation Surgery},
year = {2017},
doi = {10.1093/jhps/hnx011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Intensive Care Medicine 2021
Open access · CC-BY
Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS
Expert Opinion on Biological Therapy 2015
Preprint · OA
Therapeutic application of mesenchymal stem cells in osteoarthritis
University Hospital, Strasbourg, France 2024
Open access · US-GOV
Geriatric Assessment at Discharge From the Intensive Care Unit in Patients Aged 75 Years and Older: a Feasibility Study
Bone Marrow Transplantation 2010
Open access · CC-BY
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
Cell Transplantation 2014
Open access · OA
Mesenchymal Stem Cells for Treating Articular Cartilage Defects and Osteoarthritis
Biomedicines 2021
Open access · CC-BY